Unique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market
- Written by PR Newswire
Singapore-based Hilleman Laboratories, along with Bharat Biotech, confirm launch of new cholera vaccine, HILLCHOL®
Success provides "template for the internationalization of future vaccine and biologics development from Singapore" – Dr. Raman Rao, CEO, Hilleman Laboratories
Hilleman Laboratories Singapore hub advancing global health equity...
Read more: Unique International Collaboration Brings Breakthrough Oral Cholera Vaccine to Market














